# Abbott Laboratories (ABT) — Q1-2018 Earnings Results

**Report date:** 2018-04-18 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q1-2018

## Post-Earnings Brief

### Headline

Abbott Labs Misses on EPS, Stock Down 0.47%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.59 | N/A | -0.42% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Overall, management expressed caution regarding market conditions. They highlighted ongoing investments in innovation as a priority.

**Key quotes:**

> Management noted challenges in the current market environment.

> They emphasized a focus on long-term growth despite short-term pressures.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Abbott Labs reported an EPS of $0.59, slightly missing expectations, which contributed to a 0.47% decline in stock price. The lack of revenue details and forward guidance may have added to investor concerns. Management's cautious tone suggests they are navigating a challenging market but remain focused on long-term strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q1-2018_